Monopar Therapeutics Inc (MNPR)

Oct 16, 2025

Raymond James Boosts Monopar Therapeutics (MNPR) PT to $142, Maintains Strong Buy - Yahoo

Oct 16, 2025

Oct 15, 2025

Multi factor analysis applied to Monopar Therapeutics Inc.Global Markets & Detailed Earnings Play Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Heatmap analysis for Monopar Therapeutics Inc. and competitorsWeekly Trade Summary & Detailed Earnings Play Strategies - newser.com

Oct 15, 2025

Oct 15, 2025

Monopar Therapeutics Inc. Announces Oral Presentation at AASLD 2025 for Phase 2 Study on Tiomolybdate Choline in Wilson Disease - Quiver Quantitative

Oct 15, 2025

Oct 15, 2025

Rapidly Improved Cu Balance: Monopar Phase 2 ALXN1840 Selected for Oral Presentation at AASLD Nov 9 - Stock Titan

Oct 15, 2025

Oct 15, 2025

Is Monopar Therapeutics Inc. (1IY0) stock overpriced at current multiplesGap Down & Low Risk Growth Stock Ideas - newser.com

Oct 15, 2025

Oct 15, 2025

Monopar Therapeutics (NASDAQ:MNPR) Coverage Initiated at Barclays - Defense World

Oct 15, 2025

Oct 14, 2025

Key metrics from Monopar Therapeutics Inc.’s quarterly dataTrade Analysis Summary & Safe Capital Growth Trade Ideas - newser.com

Oct 14, 2025

Oct 14, 2025

Is Monopar Therapeutics Inc. forming a reversal patternQuarterly Portfolio Review & Daily Profit Focused Screening - newser.com

Oct 14, 2025

Oct 14, 2025

Monopar Therapeutics (NASDAQ:MNPR) Trading Up 16.3% After Analyst Upgrade - Defense World

Oct 14, 2025

Oct 13, 2025

Barclays Initiates Coverage of Monopar Therapeutics (MNPR) with Overweight Recommendation - Nasdaq

Oct 13, 2025

Oct 13, 2025

Barclays initiates Monopar Therapeutics stock with Overweight rating By Investing.com - Investing.com Canada

Oct 13, 2025

Oct 13, 2025

Is Monopar Therapeutics Inc. stock safe for conservative investorsWeekly Trade Recap & Free High Return Stock Watch Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

Will Monopar Therapeutics Inc. stock recover faster than peersJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com

Oct 13, 2025

Oct 13, 2025

MNPR: Barclays Initiates Coverage with Overweight Rating | MNPR Stock News - GuruFocus

Oct 13, 2025

Oct 13, 2025

This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Oct 13, 2025

Oct 13, 2025

Monopar Therapeutics initiated with an Overweight at Barclays - TipRanks

Oct 13, 2025

Oct 12, 2025

Real time social sentiment graph for Monopar Therapeutics Inc.Weekly Trade Recap & Free Community Consensus Stock Picks - newser.com

Oct 12, 2025

Oct 12, 2025

Monopar Therapeutics (NASDAQ:MNPR) Raised to Strong-Buy at Jones Trading - Defense World

Oct 12, 2025

Oct 11, 2025

Monopar Therapeutics (NASDAQ:MNPR) Stock Price Down 12.3%Here's What Happened - MarketBeat

Oct 11, 2025

Oct 11, 2025

Monopar Therapeutics (NASDAQ:MNPR) Upgraded to "Strong-Buy" at Jones Trading - MarketBeat

Oct 11, 2025

Oct 10, 2025

Monopar Therapeutics: A Healthy Dose Of Skepticism Warranted (NASDAQ:MNPR) - Seeking Alpha

Oct 10, 2025

Oct 10, 2025

Institutional scanner results for Monopar Therapeutics Inc.2025 Momentum Check & High Win Rate Trade Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Monopar Therapeutics' (MNPR) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 10, 2025

Monopar Therapeutics Inc.: Promising Prospects with ALXN1840 Acquisition and Wilson’s Disease Market Potential - TipRanks

Oct 10, 2025

Oct 10, 2025

What analysts say about Monopar Therapeutics Inc stockProtective Put Strategies & Low Risk Investment Trading - earlytimes.in

Oct 10, 2025

Oct 09, 2025

How Monopar Therapeutics Inc. (1IY0) stock reacts to monetary easingJuly 2025 Breakouts & Precise Trade Entry Recommendations - newser.com

Oct 09, 2025

Oct 06, 2025

Raymond James Maintains Monopar Therapeutics (MNPR) Strong Buy Recommendation - Nasdaq

Oct 06, 2025

Oct 06, 2025

MNPR: Raymond James Raises Price Target to $142, Maintains Stron - GuruFocus

Oct 06, 2025

Oct 06, 2025

Monopar Therapeutics (NASDAQ:MNPR) Hits New 1-Year HighTime to Buy? - MarketBeat

Oct 06, 2025

Oct 06, 2025

How to integrate Monopar Therapeutics Inc. into portfolio analysis toolsWatch List & Fast Gaining Stock Strategy Reports - newser.com

Oct 06, 2025

Oct 06, 2025

Historical volatility pattern of Monopar Therapeutics Inc. visualizedTrade Entry Summary & Entry Point Strategy Guides - newser.com

Oct 06, 2025

Oct 06, 2025

Will Monopar Therapeutics Inc. (1IY0) stock beat Nasdaq index returnsTrade Risk Summary & Long-Term Safe Investment Ideas - newser.com

Oct 06, 2025

Oct 06, 2025

Risk adjusted return profile for Monopar Therapeutics Inc. analyzedJuly 2025 Big Picture & High Return Stock Watch Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Can trapped investors hope for a rebound in Monopar Therapeutics Inc.Watch List & Fast Entry Momentum Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Using portfolio simulators with Monopar Therapeutics Inc. includedJuly 2025 Retail & Reliable Price Breakout Alerts - newser.com

Oct 05, 2025

Oct 03, 2025

Analyzing Monopar Therapeutics Inc. with risk reward ratio chartsGlobal Markets & Community Shared Stock Ideas - newser.com

Oct 03, 2025